| 
      SGA=Small for Gestational Age; LGA=Large for Gestational Age
        | Initials | Age    at assessment (months) | Full    term birth | Birth    weight 10th-90th percentiles | Weight    at assessment 3rd-97th percentiles | Height    at assessment 3rd-97th percentiles | Delayed    milestones | ≥3    dysmorphic features | Congenital    malformations | Karyotype | NT    ≥3 mm | Changes    in serum markers* | Further    diagnostics |  
        | S.S | 21 | Post    term | + | + | + |  |  |  |  |  | 1 |  |  
        | G.V | 24 | + | + | >97 | >97 | + |  |  | 46,XY |  | 2 |  |  
        | EG.N | 17 | Post    term | + | + | + |  |  |  | 46,XX |  | 1 |  |  
        | J.J | 25 | + | + | + | + |  |  |  |  |  | 1 |  |  
        | KH.L | 18 | + | + | + | + |  |  |  |  |  | 2 |  |  
        | T.S | 22 | + | + | + | + | + |  |  |  |  | 1 |  |  
        | A.A | 21 | + | + | + | + |  | + |  |  |  | 1 |  |  
        | LL.H | 28 | + | + | <3 | + |  |  |  | 46,XX |  | 1 |  |  
        | M.R | 31 | Preterm | + | + | + |  |  |  |  |  | 2 |  |  
        | R.R | 26 | + | SGA | + | + |  |  |  | 46,XY |  | 1 |  |  
        | M.L | 23 | + | + | + | + |  |  |  |  |  | 2 |  |  
        | A.T | 27 | + | + | + | + |  |  |  |  |  | 1 |  |  
        | ML.P | 23 | + | + | + | + |  |  |  | 46,XX |  | 1 |  |  
        | M.K | 26 | + | + | + | + |  | + |  |  |  | 1 |  |  
        | R.T | 30 | + | + | + |  |  | + |  | 46,XY |  | 1 |  |  
        | L.A | 20 | + | SGA | + | + |  |  |  |  |  | 1 |  |  
        | R.V | 24 | + | + | + | + |  |  |  | 46,XY |  | 1 |  |  
        | K.H | 20 | Preterm | SGA | <3 | + | + | + | ASD | 46,XX |  | 2 | + |  
        | M.H | 24 | + | + | + | + |  |  |  | 46,XX | + |  |  |  
        | E.M | 23 | + | SGA | + | + |  | + |  | 46,XX |  | 1 |  |  
        | K.T | 26 | + | + | + | + |  | + |  |  |  | 2 | + |  
        | T.T | 20 | + | + | + | + |  |  |  |  |  | 1 |  |  
        | M.S | 21 | + | + | + | + |  |  |  | 46,XX |  | 1 |  |  
        | HM.A | 19 | + | + | + | + |  |  |  | 46,XX | + |  |  |  
        | E.J | 26 | + | + | + | + |  |  |  | 46,XX |  | 1 |  |  
        | M.K | 20 | Post    term | + | + | + |  |  |  | 46,XY |  | 1 |  |  
        | J.A | 21 | Post    term | + | + | + |  |  |  | 46,XY |  | 1 |  |  
        | K. | 28 | Preterm | + | + | + |  | + |  |  | + |  |  |  
        | E.S | 33 | + | + | + | + |  | + |  | 46,XX | + |  | + |  
        | MM.K | 22 | + | SGA | + | + | + | + | VSD,    PDA | 46,XX |  | 1 | + |  
        | K.V | 23 | + | + | + | + |  | + |  | 46,XX |  | 1 | + |  
        | S.O | 20 | + | LGA | + | + |  | + |  | 46,XY | + |  | + |  
        | R.K | 21 | + | + | + | + |  |  |  |  |  | 1 | + |  
        | M.M |  | + | + |  |  |  |  | CAH | 46,XY |  | 1 | + |  
        | AK.K |  | Preterm | SGA |  |  | + | + | SRS | 46,XX |  | 3 |  |  ASD=Atrial Septal Defect; VSD=Ventricular Septal Defect; PDA= Patent Ductus Arteriousus; CAH=Congenital Adrenal Hyperplasia; SRS=Silver-Russell syndrome
 * previously described changes in first and second trimester screening, number indicating how many markers were affected
 |